Write in a clean editor, then format for Journal of Clinical Pharmacy and Therapeutics in one click — DocuGuru applies the official Wiley template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Journal of Clinical Pharmacy and Therapeutics is a peer-reviewed journal published by Wiley, covering Pharmaceutical Practices and Patient Outcomes, Pharmaceutical studies and practices, Antibiotics Pharmacokinetics and Efficacy.
| Publisher | Wiley |
|---|---|
| Reference style | Author–year (Chicago) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Journal of Clinical Pharmacy and Therapeutics 12 (3): 45–58.
Formats any DOI in Journal of Clinical Pharmacy and Therapeutics style. No sign-up. |
| Publishes research in | Pharmaceutical Practices and Patient Outcomes Pharmaceutical studies and practices Antibiotics Pharmacokinetics and Efficacy Pharmacogenetics and Drug Metabolism Pharmacovigilance and Adverse Drug Reactions |
| ISSN | 0269-4727 |
| Citation impact (2-yr) | 0.9 |
| h-index | 100 |
| i10-index | 2,054 |
| Total citations | 82,948 |
| Article processing charge | $2,500 |
| Top institutions publishing here | University of Tasmania |
| Journal website | onlinelibrary.wiley.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Interrupted time series design is the strongest, quasi-experimental approach for evaluating longitudinal effects of interventions. Segmented regression analysis is a powerful statistical method for estimating intervention effects in interrupted time series studies. In this paper, we show how segmented regression analysis can be used to evaluate policy and educational interventions intended to improve the quality…
Low compliance to prescribed medical interventions is an ever present and complex problem, especially for patients with a chronic illness. With increasing numbers of medications shown to do more good than harm when taken as prescibed, low compliance is a major problem in health care. Relevant studies were retrieved through comprehensive searches of different database…
BACKGROUND AND OBJECTIVE: Drug therapy is necessary to treat acute illness, maintain current health and prevent further decline. However, optimizing drug therapy for older patients is challenging and sometimes, drug therapy can do more harm than good. Drug utilization review tools can highlight instances of potentially inappropriate prescribing to those involved in elderly pharmacotherapy, i.e.…
The use of herbal supplements in the US has increased dramatically in recent years. These products are not regulated by the Food and Drug Administration (FDA) with the same scrutiny as conventional drugs. Patients who use herbal supplements often do so in conjunction with conventional drugs. This article is a review of potential adverse interactions…
BACKGROUND: Alzheimer's disease is characterized by a slow, progressive decline in cognitive function and behaviour. Acetylcholine esterase inhibitors are the only agents approved by the Food and Drug Administration for the treatment of Alzheimer's disease. All other agents prescribed for the treatment of Alzheimer's disease are used on an off-label basis. Current research into new…
